Severe sepsis Trials in Jena, Germany
Conditions / Severe sepsis / Jena, Germany
Severe sepsis has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02393781 | Adrenomedullin and Outcome in Severe Sepsis and Septic Shock | COMPLETED | — |
| NCT02820675 | Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions | COMPLETED | NA |
| NCT00334828 | ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis | COMPLETED | PHASE3 |
| NCT00832039 | Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis | COMPLETED | PHASE3 |
| NCT02246595 | Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction | COMPLETED | PHASE2 |
| NCT01273779 | Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis | SUSPENDED | PHASE2/PHASE3 |
| NCT00135473 | Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial) | COMPLETED | PHASE3 |
| NCT00386425 | Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) | COMPLETED | PHASE2 |
| NCT02734550 | (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis | COMPLETED | NA |
| NCT00534287 | Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock | COMPLETED | PHASE3 |